An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces a conference call on May 9, 2024, to discuss Q1 2024 financial results and business updates. Investors can pre-register for the call to receive a unique dial-in number. The call will address recent and upcoming milestones. Participants without internet access can join by phone. A webcast and replay options will be available for those unable to attend the live call.
Sensus Healthcare, Inc. (Nasdaq: SRTS) annuncia una conferenza telefonica il 9 maggio 2024 per discutere i risultati finanziari del primo trimestre del 2024 e gli aggiornamenti aziendali. Gli investitori possono preregistrarsi alla chiamata per ricevere un numero di accesso unico. Durante la chiamata verranno discussi i recenti e futuri traguardi. I partecipanti senza accesso a internet possono unirsi tramite telefono. Saranno disponibili un webcast e delle opzioni di replay per coloro che non potranno partecipare alla chiamata in diretta.
Sensus Healthcare, Inc. (Nasdaq: SRTS) anuncia una llamada de conferencia el 9 de mayo de 2024 para discutir los resultados financieros del primer trimestre de 2024 y actualizaciones del negocio. Los inversores pueden pre-registrarse para la llamada para recibir un número único de acceso. La llamada tratará sobre los hitos recientes y próximos. Los participantes sin acceso a internet pueden unirse por teléfono. Habrá una transmisión web y opciones de repetición disponibles para aquellos que no puedan asistir a la llamada en vivo.
센서스 헬스케어, Inc. (나스닥: SRTS)는 2024년 5월 9일에 2024년 1분기 재무 결과 및 비즈니스 업데이트를 논의하기 위한 컨퍼런스 콜을 발표합니다. 투자자는 고유한 다이얼인 번호를 받기 위해 사전 등록할 수 있습니다. 이 콜에서는 최근 및 향후 이정표에 대해 논의될 예정입니다. 인터넷 접속이 없는 참가자는 전화로 참여할 수 있습니다. 라이브 콜에 참석할 수 없는 사람들을 위해 웹캐스트 및 재생 옵션이 제공될 것입니다.
Sensus Healthcare, Inc. (Nasdaq : SRTS) annonce une conférence téléphonique le 9 mai 2024 pour discuter des résultats financiers du premier trimestre 2024 et des mises à jour commerciales. Les investisseurs peuvent se pré-enregistrer pour l'appel afin de recevoir un numéro d'accès unique. L'appel abordera les jalons récents et à venir. Les participants sans accès internet peuvent rejoindre par téléphone. Une webdiffusion et des options de replay seront disponibles pour ceux qui ne peuvent pas assister à l'appel en direct.
Sensus Healthcare, Inc. (Nasdaq: SRTS) kündigt für den 9. Mai 2024 eine Telefonkonferenz an, um die Finanzergebnisse des ersten Quartals 2024 und Geschäftsaktualisierungen zu besprechen. Investoren können sich für den Anruf vorab registrieren, um eine einzigartige Einwahlnummer zu erhalten. Der Anruf wird aktuelle und kommende Meilensteine behandeln. Teilnehmer ohne Internetzugang können per Telefon teilnehmen. Für diejenigen, die den Live-Anruf nicht wahrnehmen können, werden ein Webcast und Wiederholungsoptionen bereitgestellt.
Positive
None.
Negative
None.
BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 1-844-481-2811 (U.S. and Canada Toll Free) or 1-412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until June 9th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International). At the system prompt, dial the replay code – 9785929 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings.
Contact: LHA Investor Relations Kim Sutton Golodetz 212-838-3777 kgolodetz@lhai.com
# # #
FAQ
When is the conference call scheduled by Sensus Healthcare, Inc. (SRTS)?
Sensus Healthcare, Inc. (Nasdaq: SRTS) will hold a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024.
What is the focus of the conference call by Sensus Healthcare, Inc. (SRTS)?
The conference call by Sensus Healthcare, Inc. (Nasdaq: SRTS) will provide a business update and discuss recent and upcoming milestones.
How can participants pre-register for the conference call by Sensus Healthcare, Inc. (SRTS)?
Participants can pre-register for the conference call by Sensus Healthcare, Inc. (Nasdaq: SRTS) using a provided link to receive a unique dial-in number.
What options are available for participants without internet access to join the conference call by Sensus Healthcare, Inc. (SRTS)?
Participants without internet access can join the conference call by dialing 1-844-481-2811 (U.S. and Canada Toll Free) or 1-412-317-0676 (International).
How long will the replay of the conference call by Sensus Healthcare, Inc. (SRTS) be available?
A telephone replay of the conference call by Sensus Healthcare, Inc. (Nasdaq: SRTS) will be available until June 9th by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International) and entering the replay code – 9785929.
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
